Norovirus and histo-blood group antigens - PubMed

Affiliations

• PMID: 21519121

Review

Norovirus and histo-blood group antigens

Haruko Shirato. Jpn J Infect Dis. 2011.

Abstract

Norovirus (NoV), a member of the family Caliciviridae, is a major cause of acute water- and food-borne nonbacterial gastroenteritis and forms antigenically diverse groups of viruses. Human NoVs are divided into at least three genogroups, genogroups I (GI), GII, and GIV, which contain at least 15, 18, and 1 genotypes, respectively. Except for a few genotypes, all NoVs bind to histo-blood group antigens (HBGAs), namely ABH antigens and Lewis antigens, in which carbohydrate core structures, (types 1 and 2) constitute antigenically distinct phenotypes. Volunteer challenge studies have indicated that carbohydrate binding is essential for genogroup I genotype 1 (GI/1) infection. Non-secretors who do not express FUT2 fucosyltransferase, and consequently do not express H type 1 or Lewis b antigens in the gut, are not infected after challenge with GI/1. NoV virus-like particles (VLPs), which are recombinant particles that are morphologically and antigenically similar to the native virion, display different ABH and Le carbohydrate-binding profiles in vitro. Epidemiological studies have shown that individuals with different ABH phenotypes are infected with NoV strains in a genotype-specific manner. On the other hand, an in vitro binding assay using NoV VLPs showed a uniform recognition pattern against type 1 and 2 core structures, and bind more tightly to type 1 carbohydrates than to type 2. Type 1 carbohydrates are expressed at the surface of the small intestine and are presumably targeted by NoV. This property may afford NoV tissue specificity. GII/4 includes global epidemic strains and binds to more HBGAs than other genogroups. This characteristic may be linked to the worldwide transmission of GII/4 strains. Although it is still unclear whether HBGAs act as primary receptors or enhance NoV infectivity, they are important factors in determining tissue specificity and the risk of transmission.

Similar articles

• Genetic susceptibility to symptomatic norovirus infection in Nicaragua.

  Bucardo F, Kindberg E, Paniagua M, Grahn A, Larson G, Vildevall M, Svensson L. Bucardo F, et al. J Med Virol. 2009 Apr;81(4):728-35. doi: 10.1002/jmv.21426. J Med Virol. 2009. PMID: 19235844

• [Interaction between noroviruses and human histo-blood group antigens].

  Shirato-Horikoshi H, Takeda N. Shirato-Horikoshi H, et al. Uirusu. 2007 Dec;57(2):181-9. doi: 10.2222/jsv.57.181. Uirusu. 2007. PMID: 18357756 Review. Japanese.

• Noroviruses distinguish between type 1 and type 2 histo-blood group antigens for binding.

  Shirato H, Ogawa S, Ito H, Sato T, Kameyama A, Narimatsu H, Xiaofan Z, Miyamura T, Wakita T, Ishii K, Takeda N. Shirato H, et al. J Virol. 2008 Nov;82(21):10756-67. doi: 10.1128/JVI.00802-08. Epub 2008 Aug 13. J Virol. 2008. PMID: 18701592 Free PMC article.

• [Noroviruses--tactic of spread].

  Gospodarek E, Zalas-Wiecek P. Gospodarek E, et al. Przegl Epidemiol. 2009;63(1):5-9. Przegl Epidemiol. 2009. PMID: 19522218 Review. Polish.

• Outbreak studies of a GII-3 and a GII-4 norovirus revealed an association between HBGA phenotypes and viral infection.

  Tan M, Jin M, Xie H, Duan Z, Jiang X, Fang Z. Tan M, et al. J Med Virol. 2008 Jul;80(7):1296-301. doi: 10.1002/jmv.21200. J Med Virol. 2008. PMID: 18461617

Cited by

• Norovirus.

  Robilotti E, Deresinski S, Pinsky BA. Robilotti E, et al. Clin Microbiol Rev. 2015 Jan;28(1):134-64. doi: 10.1128/CMR.00075-14. Clin Microbiol Rev. 2015. PMID: 25567225 Free PMC article. Review.

• Current and Future Antiviral Strategies to Tackle Gastrointestinal Viral Infections.

  Santos-Ferreira N, Van Dycke J, Neyts J, Rocha-Pereira J. Santos-Ferreira N, et al. Microorganisms. 2021 Jul 27;9(8):1599. doi: 10.3390/microorganisms9081599. Microorganisms. 2021. PMID: 34442677 Free PMC article. Review.

• Controlled Human Infection Models To Accelerate Vaccine Development.

  Choy RKM, Bourgeois AL, Ockenhouse CF, Walker RI, Sheets RL, Flores J. Choy RKM, et al. Clin Microbiol Rev. 2022 Sep 21;35(3):e0000821. doi: 10.1128/cmr.00008-21. Epub 2022 Jul 6. Clin Microbiol Rev. 2022. PMID: 35862754 Free PMC article. Review.

• Current tools for norovirus drug discovery.

  Weerasekara S, Prior AM, Hua DH. Weerasekara S, et al. Expert Opin Drug Discov. 2016 Jun;11(6):529-41. doi: 10.1080/17460441.2016.1178231. Epub 2016 May 2. Expert Opin Drug Discov. 2016. PMID: 27108716 Free PMC article. Review.

• Bitter-sweet symphony: glycan-lectin interactions in virus biology.

  Van Breedam W, Pöhlmann S, Favoreel HW, de Groot RJ, Nauwynck HJ. Van Breedam W, et al. FEMS Microbiol Rev. 2014 Jul;38(4):598-632. doi: 10.1111/1574-6976.12052. Epub 2013 Dec 6. FEMS Microbiol Rev. 2014. PMID: 24188132 Free PMC article. Review.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Medical

  • MedlinePlus Health Information

• Research Materials

  • NCI CPTC Antibody Characterization Program